Literature DB >> 18642886

Computationally designed peptide inhibitors of protein-protein interactions in membranes.

Gregory A Caputo1, Rustem I Litvinov, Wei Li, Joel S Bennett, William F Degrado, Hang Yin.   

Abstract

We recently reported a computational method (CHAMP) for designing sequence-specific peptides that bind to the membrane-embedded portions of transmembrane proteins. We successfully applied this method to design membrane-spanning peptides targeting the transmembrane domains of the alpha IIb subunit of integrin alpha IIbbeta 3. Previously, we demonstrated that these CHAMP peptides bind specifically with reasonable affinity to isolated transmembrane helices of the targeted transmembrane region. These peptides also induced integrin alpha IIbbeta 3 activation due to disruption of the helix-helix interactions between the transmembrane domains of the alpha IIb and beta 3 subunits. In this paper, we show the direct interaction of the designed anti-alpha IIb CHAMP peptide with isolated full-length integrin alpha IIbbeta 3 in detergent micelles. Further, the behavior of the designed peptides in phospholipid bilayers is essentially identical to their behavior in detergent micelles. In particular, the peptides assume a membrane-spanning alpha-helical conformation that does not disrupt bilayer integrity. The activity and selectivity of the CHAMP peptides were further explored in platelets, comfirming that anti-alpha IIb activates wild-type alpha IIbbeta 3 in whole cells as a result of its disruption of the protein-protein interactions between the alpha and beta subunits in the transmembrane regions. These results demonstrate that CHAMP is a successful chemical biology approach that can provide specific tools for probing the transmembrane domains of proteins.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18642886      PMCID: PMC2719017          DOI: 10.1021/bi800687h

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  31 in total

1.  RGD-containing peptides inhibit fibrinogen binding to platelet alpha(IIb)beta3 by inducing an allosteric change in the amino-terminal portion of alpha(IIb).

Authors:  R B Basani; G D'Andrea; N Mitra; G Vilaire; M Richberg; M A Kowalska; J S Bennett; M Poncz
Journal:  J Biol Chem       Date:  2001-01-18       Impact factor: 5.157

2.  De novo design, synthesis, and characterization of antimicrobial beta-peptides.

Authors:  D Liu; W F DeGrado
Journal:  J Am Chem Soc       Date:  2001-08-08       Impact factor: 15.419

3.  High-yield synthesis and purification of an alpha-helical transmembrane domain.

Authors:  L E Fisher; D M Engelman
Journal:  Anal Biochem       Date:  2001-06-01       Impact factor: 3.365

4.  Computer-aided design of a PDZ domain to recognize new target sequences.

Authors:  Jose Reina; Emmanuel Lacroix; Scott D Hobson; Gregorio Fernandez-Ballester; Vladimir Rybin; Markus S Schwab; Luis Serrano; Cayetano Gonzalez
Journal:  Nat Struct Biol       Date:  2002-08

Review 5.  How do helix-helix interactions help determine the folds of membrane proteins? Perspectives from the study of homo-oligomeric helical bundles.

Authors:  William F DeGrado; Holly Gratkowski; James D Lear
Journal:  Protein Sci       Date:  2003-04       Impact factor: 6.725

6.  Bidirectional transmembrane signaling by cytoplasmic domain separation in integrins.

Authors:  Minsoo Kim; Christopher V Carman; Timothy A Springer
Journal:  Science       Date:  2003-09-19       Impact factor: 47.728

Review 7.  Novel platelet inhibitors.

Authors:  J S Bennett
Journal:  Annu Rev Med       Date:  2001       Impact factor: 13.739

8.  Cumulative effects of amino acid substitutions and hydrophobic mismatch upon the transmembrane stability and conformation of hydrophobic alpha-helices.

Authors:  Gregory A Caputo; Erwin London
Journal:  Biochemistry       Date:  2003-03-25       Impact factor: 3.162

9.  Assembly and topography of the prepore complex in cholesterol-dependent cytolysins.

Authors:  Alejandro P Heuck; Rodney K Tweten; Arthur E Johnson
Journal:  J Biol Chem       Date:  2003-05-30       Impact factor: 5.157

Review 10.  Exogenous agents that target transmembrane domains of proteins.

Authors:  Hang Yin
Journal:  Angew Chem Int Ed Engl       Date:  2008       Impact factor: 15.336

View more
  33 in total

Review 1.  Structure elucidation of dimeric transmembrane domains of bitopic proteins.

Authors:  Eduard V Bocharov; Pavel E Volynsky; Konstantin V Pavlov; Roman G Efremov; Alexander S Arseniev
Journal:  Cell Adh Migr       Date:  2010-05-01       Impact factor: 3.405

Review 2.  Integrins as therapeutic targets: lessons and opportunities.

Authors:  Dermot Cox; Marian Brennan; Niamh Moran
Journal:  Nat Rev Drug Discov       Date:  2010-10       Impact factor: 84.694

Review 3.  Computational protein design: engineering molecular diversity, nonnatural enzymes, nonbiological cofactor complexes, and membrane proteins.

Authors:  Jeffery G Saven
Journal:  Curr Opin Chem Biol       Date:  2011-04-12       Impact factor: 8.822

4.  Beta-peptides with improved affinity for hDM2 and hDMX.

Authors:  Elizabeth A Harker; Douglas S Daniels; Danielle A Guarracino; Alanna Schepartz
Journal:  Bioorg Med Chem       Date:  2009-01-23       Impact factor: 3.641

5.  Structural basis of transmembrane domain interactions in integrin signaling.

Authors:  Tobias S Ulmer
Journal:  Cell Adh Migr       Date:  2010-04-10       Impact factor: 3.405

Review 6.  Interaction and conformational dynamics of membrane-spanning protein helices.

Authors:  Dieter Langosch; Isaiah T Arkin
Journal:  Protein Sci       Date:  2009-07       Impact factor: 6.725

7.  De novo designed transmembrane peptides activating the α5β1 integrin.

Authors:  Marco Mravic; Hailin Hu; Zhenwei Lu; Joel S Bennett; Charles R Sanders; A Wayne Orr; William F DeGrado
Journal:  Protein Eng Des Sel       Date:  2018-05-01       Impact factor: 1.650

8.  Biased suppression of TP homodimerization and signaling through disruption of a TM GxxxGxxxL helical interaction motif.

Authors:  Alexander J Frey; Salam Ibrahim; Scott Gleim; John Hwa; Emer M Smyth
Journal:  J Lipid Res       Date:  2013-03-14       Impact factor: 5.922

Review 9.  T-cell antigen receptor (TCR) transmembrane peptides: A new paradigm for the treatment of autoimmune diseases.

Authors:  Nicholas Manolios; Marina Ali; Vera Bender
Journal:  Cell Adh Migr       Date:  2010-04-30       Impact factor: 3.405

10.  Mechanistic Basis for the Binding of RGD- and AGDV-Peptides to the Platelet Integrin αIIbβ3.

Authors:  Olga Kononova; Rustem I Litvinov; Dmitry S Blokhin; Vladimir V Klochkov; John W Weisel; Joel S Bennett; Valeri Barsegov
Journal:  Biochemistry       Date:  2017-03-22       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.